Chemical biology news from across RSC Publishing.
Peptides provide fatal blow for cancer cells
21 April 2008
Peptide nanostructures that punch holes in cancer cells are 'the first step towards efficient nanochemotherapeutics,' say chemists in Canada.
Normand Voyer and colleagues at the University of Laval in Québec have designed a series of modified peptide nanostructures that can puncture cancer cell membranes, leading to the cells' death.
Basing their structures on a membrane-disrupting peptide they had made previously, the researchers engineered analogues that would be selective for cancer cells. The engineered peptides are inactive until they reach cancer cell surfaces where they convert into an active cell membrane disruption agent. Since the enzyme that activates the peptides is over-expressed in prostate cancer cells, normal cells do not activate the peptide to the same extent, leading to the peptides' selectivity.
When cancer cells (left) are treated with peptide nanostructures their cell membranes are destroyed (right)
Vincent Rotello, an expert in the supramolecular chemistry of biological and materials systems at the University of Massachusetts, Amherst, US, is enthusiastic about the findings. 'While enzymatic activation has been used before for therapeutics,' he says, 'this peptide-based scaffold has great promise due to the modular nature of its construction.' This is because the amino acid building blocks used to assemble the peptides can be readily varied, which provides 'incredible control over the structure and dynamics of the eventual therapeutics,' Rotello adds.
Voyer explains that the work 'illustrates chemists' abilities to design novel nanometre-sized molecular architectures from scratch to address highly challenging problems.' Future efforts will be geared towards 'determining the mechanism of action of this new class of antitumour agents,' he adds.
Link to journal article
Nanoscale tools to selectively destroy cancer cells
Pierre-Luc Boudreault, Mathieu Arseneault, François Otis and Normand Voyer, Chem. Commun., 2008, 2118
Also of interest
A method to identify the biologically active sections of peptoids could simplify the drug development process.
Phosphorus compounds made by scientists in India and the US have shown anticancer activity without using metals.